Boehringer Ingelheim, a leading research-driven biopharmaceutical company, has premiered a new short film as part of a campaign to raise awareness of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis, two progressive lung conditions that can have a profound impact on patients’ everyda